Employees: 03 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2004-10-01 (21 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT-DENIS (97417), La Reunion
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
EURL PHARMACIE RUISSEAU BLANC is a French company
founded 21 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT-DENIS (97417),
this company of category PME
shows in 2024 a net income positive of 180 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - EURL PHARMACIE RUISSEAU BLANC (SIREN 482028958)
Indicator
2024
2023
Revenue
N/C
N/C
Net income
180 138 €
13 597 €
EBITDA
N/C
N/C
Net margin
N/C
N/C
Revenue and income statement
In 2024, EURL PHARMACIE RUISSEAU BLANC generates positive net income of 180 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2023-2024: 14 k€ -> 180 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
180 138 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 137%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 36%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
136.723%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
35.734%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2023
2024
Debt ratio
2.327
136.723
Financial autonomy
44.071
35.734
Repayment capacity
None
None
Cash flow / Revenue
None%
None%
Sector positioning
Debt ratio
136.722024
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average+45 pts over 2 years
In 2024, the debt ratio of EURL PHARMACIE RUISSEAU B... (136.72) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
35.73%2024
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average-11 pts over 2 years
In 2024, the financial autonomy of EURL PHARMACIE RUISSEAU B... (35.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 177.15. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2023
2024
Liquidity ratio
175.836
177.154
Interest coverage
None
None
Sector positioning
Liquidity ratio
177.152024
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Average
In 2024, the liquidity ratio of EURL PHARMACIE RUISSEAU B... (177.15) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of EURL PHARMACIE RUISSEAU BLANC in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of EURL PHARMACIE RUISSEAU BLANC is estimated at
2 514 859 €
(range 1 751 308€ - 3 762 373€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1751k€2514k€3762k€
2 514 859 €Range: 1 751 308€ - 3 762 373€
NAF 5 année 2024
Valuation method used
Net Income Multiple
180 138 €
×
14.0x
=2 514 860 €
Range: 1 751 308€ - 3 762 374€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare EURL PHARMACIE RUISSEAU BLANC with other companies in the same sector:
Frequently asked questions about EURL PHARMACIE RUISSEAU BLANC
What is the revenue of EURL PHARMACIE RUISSEAU BLANC ?
The revenue of EURL PHARMACIE RUISSEAU BLANC is not publicly disclosed (confidential accounts filed with INPI).
Is EURL PHARMACIE RUISSEAU BLANC profitable?
Yes, EURL PHARMACIE RUISSEAU BLANC generated a net profit of 180 k€ in 2024.
Where is the headquarters of EURL PHARMACIE RUISSEAU BLANC ?
The headquarters of EURL PHARMACIE RUISSEAU BLANC is located in SAINT-DENIS (97417), in the department La Reunion.
Where to find the tax return of EURL PHARMACIE RUISSEAU BLANC ?
The tax return of EURL PHARMACIE RUISSEAU BLANC is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does EURL PHARMACIE RUISSEAU BLANC operate?
EURL PHARMACIE RUISSEAU BLANC operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart